News stories about Concord Medical Services (NYSE:CCM) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Concord Medical Services earned a daily sentiment score of 0.17 on Accern’s scale. Accern also assigned news articles about the company an impact score of 43.8954224874136 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

CCM has been the subject of a number of research analyst reports. Zacks Investment Research lowered Concord Medical Services from a “hold” rating to a “sell” rating in a report on Wednesday, June 27th. ValuEngine upgraded Concord Medical Services from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd.

Shares of CCM traded up $0.35 during mid-day trading on Friday, reaching $3.75. The company’s stock had a trading volume of 1,150 shares, compared to its average volume of 1,439. The firm has a market capitalization of $147.44 million, a P/E ratio of -3.68 and a beta of 0.63. Concord Medical Services has a 1 year low of $2.46 and a 1 year high of $4.29. The company has a quick ratio of 1.00, a current ratio of 1.00 and a debt-to-equity ratio of 0.44.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services.

Featured Story: How are Outstanding Shares Different from Authorized Shares?

Insider Buying and Selling by Quarter for Concord Medical Services (NYSE:CCM)

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with's FREE daily email newsletter.